[Seite 34↓]

5.  Literaturverzeichnis

Adlkofer, K. and Lai, C. (2000): Role of neuregulins in glial cell development, Glia 29 [2], pp.104-11..

Akiyama, H.; Chaboissier, M. C.; Martin, J. F.; Schedl, A. and de Crombrugghe, B. (2002): The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6, Genes Dev 16 [21], pp.2813-28.

Anderson, D. J.; Groves, A.; Lo, L.; Ma, Q.; Rao, M.; Shah, N. M. and Sommer, L. (1997): Cell lineage determination and the control of neuronal identity in the neural crest, Cold Spring Harb Symp Quant Biol 62, pp.493-504.

Anderson, K. V. and Ingham, P. W. (2003): The transformation of the model organism: a decade of developmental genetics, Nat Genet 33 Suppl, pp.285-93.

Artavanis-Tsakonas, S.; Rand, M. D. and Lake, R. J. (1999): Notch signaling: cell fate control and signal integration in development, Science 284 [5415], pp.770-6.

Baker, N. E. (2000): Notch signaling in the nervous system. Pieces still missing from the puzzle, Bioessays 22 [3], pp.264-73.

Bao, J.; Wolpowitz, D.; Role, L. W. and Talmage, D. A. (2003): Back signaling by the Nrg-1 intracellular domain, J Cell Biol 161 [6], pp.1133-41.

Bermingham-McDonogh, O.; Xu, Y. T.; Marchionni, M. A. and Scherer, S. S. (1997): Neuregulin expression in PNS neurons: isoforms and regulation by target interactions, Mol Cell Neurosci 10 [3-4], pp.184-95.

Bibel, M. and Barde, Y. A. (2000): Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system, Genes Dev 14 [23], pp.2919-37.

Bondurand, N.; Girard, M.; Pingault, V.; Lemort, N.; Dubourg, O. and Goossens, M. (2001): Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10, Hum Mol Genet 10 [24], pp.2783-95.

Bondurand, N.; Kuhlbrodt, K.; Pingault, V.; Enderich, J.; Sajus, M.; Tommerup, N.; Warburg, M.; Hennekam, R. C.; Read, A. P.; Wegner, M. and Goossens, M. (1999): A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies, Hum Mol Genet 8 [9], pp.1785-9.

Britsch, S.; Goerich, D. E.; Riethmacher, D.; Peirano, R. I.; Rossner, M.; Nave, K. A.; Birchmeier, C. and Wegner, M. (2001): The transcription factor Sox10 is a key regulator of peripheral glial development, Genes Dev 15 [1], pp.66-78..

Britsch, S.; Li, L.; Kirchhoff, S.; Theuring, F.; Brinkmann, V.; Birchmeier, C. and Riethmacher, D. (1998): The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system, Genes Dev 12 [12], pp.1825-36..

Britsch, S.; Strehle, M. and Birchmeier, C. (2003): Tiermodelle in der Biomedizinischen Forschung., Ganten, D. and Ruckpaul, K., Eds, Handbuch der Molekularen Medizin, Bd. 1, Molekular und Zellbiologische Grundlagen 2. Auflage, Springer Verlag, Heidelberg, New York.

Brockes, J. P.; Lemke, G. E. and Balzer, D. R., Jr. (1980): Purification and preliminary characterization of a glial growth factor from the bovine pituitary, J Biol Chem 255 [18], pp.8374-7.

Bunge, R. P. (1993): Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration, Curr Opin Neurobiol 3 [5], pp.805-9.

Buonanno, A. and Fischbach, G. D. (2001): Neuregulin and ErbB receptor signaling pathways in the nervous system, Curr Opin Neurobiol 11 [3], pp.287-96.

Burden, S. and Yarden, Y. (1997): Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis, Neuron 18 [6], pp.847-55..

Busfield, S. J.; Michnick, D. A.; Chickering, T. W.; Revett, T. L.; Ma, J.; Woolf, E. A.; Comrack, C. A.; Dussault, B. J.; Woolf, J.; Goodearl, A. D. and Gearing, D. P. (1997): Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus, Mol Cell Biol 17 [7], pp.4007-14.

Carraway, K. L., 3rd; Weber, J. L.; Unger, M. J.; Ledesma, J.; Yu, N.; Gassmann, M. and Lai, C. (1997): Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases, Nature 387 [6632], pp.512-6.

Carraway, Kl 3rd and Cantley, L. C. (1994): A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling, Cell 78 [1], pp.5-8.

Carraway, Kl 3rd; Sliwkowski, M. X.; Akita, R.; Platko, J. V.; Guy, P. M.; Nuijens, A.; Diamonti, A. J.; Vandlen, R. L.; Cantley, L. C. and Cerione, R. A. (1994): The erbB3 gene product is a receptor for heregulin, J. Biol. Chem. 269 [19], pp.14303-6.

Citri, A.; Skaria, K. B. and Yarden, Y. (2003): The deaf and the dumb: the biology of ErbB-2 and ErbB-3, Exp Cell Res 284 [1], pp.54-65.

Dong, Z.; Brennan, A.; Liu, N.; Yarden, Y.; Lefkowitz, G.; Mirsky, R. and Jessen, K. R. (1995): Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors, Neuron 15 [3], pp.585-96.

Dottori, M.; Gross, M. K.; Labosky, P. and Goulding, M. (2001): The winged-helix transcription factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell fate, Development 128 [21], pp.4127-38.

Durbec, P. L.; Larsson-Blomberg, L. B.; Schuchardt, A.; Costantini, F. and Pachnis, V. (1996): Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts, Development 122 [1], pp.349-58.

Erickson, S. L.; O'Shea, K. S.; Ghaboosi, N.; Loverro, L.; Frantz, G.; Bauer, M.; Lu, L. H. and Moore, M. W. (1997): ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice, Development 124 [24], pp.4999-5011..

Falls, D. L. (2003): Neuregulins: functions, forms, and signaling strategies, Exp Cell Res 284 [1], pp.14-30.

Falls, D. L.; Rosen, K. M.; Corfas, G.; Lane, W. S. and Fischbach, G. D. (1993): ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family, Cell 72 [5], pp.801-15.

Garratt, A. N.; Britsch, S. and Birchmeier, C. (2000): Neuregulin, a factor with many functions in the life of a schwann cell, Bioessays 22 [11], pp.987-96..

Garratt, A. N.; Ozcelik, C. and Birchmeier, C. (2003): ErbB2 pathways in heart and neural diseases, Trends Cardiovasc Med 13 [2], pp.80-6.

Gassmann, M.; Casagranda, F.; Orioli, D.; Simon, H.; Lai, C.; Klein, R. and Lemke, G. (1995): Aberrant neural and cardiac development in mice lacking the erbb4 neuregulin receptor, Nature 378 [6555], pp.390-394.

Goodearl, A. D.; Davis, J. B.; Mistry, K.; Minghetti, L.; Otsu, M.; Waterfield, M. D. and Stroobant, P. (1993): Purification of multiple forms of glial growth factor, J Biol Chem 268 [24], pp.18095-102.

Halata, Z.; Grim, M. and Bauman, K. I. (2003): Friedrich Sigmund Merkel and his "Merkel cell", morphology, development, and physiology: review and new results, Anat Rec 271A [1], pp.225-39.

Harari, D.; Tzahar, E.; Romano, J.; Shelly, M.; Pierce, J. H.; Andrews, G. C. and Yarden, Y. (1999): Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase, Oncogene 18 [17], pp.2681-9.

Herbarth, B.; Pingault, V.; Bondurand, N.; Kuhlbrodt, K.; Hermans-Borgmeyer, I.; Puliti, A.; Lemort, N.; Goossens, M. and Wegner, M. (1998): Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease, Proc Natl Acad Sci U S A 95 [9], pp.5161-5.

Higashiyama, S.; Horikawa, M.; Yamada, K.; Ichino, N.; Nakano, N.; Nakagawa, T.; Miyagawa, J.; Matsushita, N.; Nagatsu, T.; Taniguchi, N. and Ishiguro, H. (1997): A novel brain-derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4, J Biochem (Tokyo) 122 [3], pp.675-80.

Holmes, W. E.; Sliwkowski, M. X.; Akita, R. W.; Henzel, W. J.; Lee, J.; Park, J. W.; Yansura, D.; Abadi, N.; Raab, H.; Lewis, G. D. and et, a. l. (1992): Identification of heregulin, a specific activator of p185erbB2, Science 256 [5060], pp.1205-10.

Howard, M. J.; Stanke, M.; Schneider, C.; Wu, X. and Rohrer, H. (2000): The transcription factor dHAND is a downstream effector of BMPs in sympathetic neuron specification, Development 127 [18], pp.4073-81.

Huotari, M. A.; Miettinen, P. J.; Palgi, J.; Koivisto, T.; Ustinov, J.; Harari, D.; Yarden, Y. and Otonkoski, T. (2002): ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture, Endocrinology 143 [11], pp.4437-46.

Ingham, P. W. and McMahon, A. P. (2001): Hedgehog signaling in animal development: paradigms and principles, Genes Dev 15 [23], pp.3059-87.

Inoue, K.; Tanabe, Y. and Lupski, J. R. (1999): Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation, Ann Neurol 46 [3], pp.313-8.

Jessell, T. M. (2000): Neuronal specification in the spinal cord: inductive signals and transcriptional codes, Nat Rev Genet 1 [1], pp.20-9.

Jessell, T. M.; Siegel, R. E. and Fischbach, G. D. (1979): Induction of acetylcholine receptors on cultured skeletal muscle by a factor extracted from brain and spinal cord, Proc Natl Acad Sci U S A 76 [10], pp.5397-401.

Jessen, K. R. and Mirsky, R. (2002): Signals that determine Schwann cell identity, J Anat 200 [4], pp.367-76.

Kamachi, Y.; Uchikawa, M. and Kondoh, H. (2000): Pairing SOX off: with partners in the regulation of embryonic development, Trends Genet 16 [4], pp.182-7.

Kapur, R. P. (1999): Early death of neural crest cells is responsible for total enteric aganglionosis in Sox10(Dom)/Sox10(Dom) mouse embryos, Pediatr Dev Pathol 2 [6], pp.559-69.

Kim, J.; Lo, L.; Dormand, E. and Anderson, D. J. (2003): SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells, Neuron 38 [1], pp.17-31.

King, C. R.; Borrello, I.; Bellot, F.; Comoglio, P. and Schlessinger, J. (1988): EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3, Embo J. 7 [6], pp.1647-51.

Kolodkin, A. L. (1998): Semaphorin-mediated neuronal growth cone guidance, Prog Brain Res 117, pp.115-32.

Kramer, R.; Bucay, N.; Kane, D. J.; Martin, L. E.; Tarpley, J. E. and Theill, L. E. (1996): Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development, Proc Natl Acad Sci U S A 93 [10], pp.4833-8.

Kuhlbrodt, K.; Herbarth, B.; Sock, E.; Hermans-Borgmeyer, I. and Wegner, M. (1998): Sox10, a novel transcriptional modulator in glial cells, J Neurosci 18 [1], pp.237-50.

Kuhlbrodt, K.; Schmidt, C.; Sock, E.; Pingault, V.; Bondurand, N.; Goossens, M. and Wegner, M. (1998): Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients, J Biol Chem 273 [36], pp.23033-8.

Kurtz, A.; Zimmer, A.; Schnutgen, F.; Bruning, G.; Spener, F. and Muller, T. (1994): The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development, Development 120 [9], pp.2637-49.

Lane, P. W. and Liu, H. M. (1984): Association of megacolon with a new dominant spotting gene (Dom) in the mouse, J Hered 75 [6], pp.435-9.

Lang, D.; Chen, F.; Milewski, R.; Li, J.; Lu, M. M. and Epstein, J. A. (2000): Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret, J Clin Invest 106 [8], pp.963-71.

Lang, D. and Epstein, J. A. (2003): Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer, Hum Mol Genet 12 [8], pp.937-45.

Le Douarin, N and Kalcheim, C (1999): The Neural Crest 36, second. ed., Developmental and Cell Biology, Cambridge University Press.

Lee, K. F.; Simon, H.; Chen, H.; Bates, B.; Hung, M. C. and Hauser, C. (1995): Requirement for neuregulin receptor erbB2 in neural and cardiac development [see comments], Nature 378 [6555], pp.394-8.

Lee, K. J. and Jessell, T. M. (1999): The specification of dorsal cell fates in the vertebrate central nervous system, Annu Rev Neurosci 22, pp.261-94.

Lemke, G. (1996): Neuregulins in development, Mol Cell Neurosci 7 [4], pp.247-62..

Lemke, G. E. and Brockes, J. P. (1984): Identification and purification of glial growth factor, J Neurosci 4 [1], pp.75-83.

Lewandoski, M. (2001): Conditional control of gene expression in the mouse, Nat Rev Genet 2 [10], pp.743-55.

Liu, X.; Hwang, H.; Cao, L.; Buckland, M.; Cunningham, A.; Chen, J.; Chien, K. R.; Graham, R. M. and Zhou, M. (1998): Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail, Proc Natl Acad Sci U S A 95 [22], pp.13024-9.

Ma, Q.; Fode, C.; Guillemot, F. and Anderson, D. J. (1999): Neurogenin1 and neurogenin2 control two distinct waves of neurogenesis in developing dorsal root ganglia, Genes Dev 13 [13], pp.1717-28.

Mahanthappa, N. K.; Anton, E. S. and Matthew, W. D. (1996): Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth, J Neurosci 16 [15], pp.4673-83.

Marchionni, M. A.; Goodearl, A. D.; Chen, M. S.; Bermingham, McDonogh O.; Kirk, C.; Hendricks, M.; Danehy, F.; Misumi, D.; Sudhalter, J.; Kobayashi, K. and et, a. l. (1993): Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system [see comments], Nature 362 [6418], pp.312-8.

Massague, J.; Blain, S. W. and Lo, R. S. (2000): TGFbeta signaling in growth control, cancer, and heritable disorders, Cell 103 [2], pp.295-309.

Meyer, D. and Birchmeier, C. (1994): Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development, Proc Natl Acad Sci U S A 91 [3], pp.1064-8..

Meyer, D. and Birchmeier, C. (1995): Multiple essential functions of neuregulin in development [see comments], Nature 378 [6555], pp.386-90.

Meyer, D.; Yamaai, T.; Garratt, A.; Riethmacher-Sonneberg, E.; Kane, D. ; Theill, L. and Birchmeier, C. (1997): Isoform specific expression and function of neuregulin., Development 124, pp.3575-3586.

Mollaaghababa, R. and Pavan, W. J. (2003): The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia, Oncogene 22 [20], pp.3024-34.

Morris, J. K.; Lin, W.; Hauser, C.; Marchuk, Y.; Getman, D. and Lee, K. F. (1999): Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development, Neuron 23 [2], pp.273-83..

Morrison, S. J.; Perez, S. E.; Qiao, Z.; Verdi, J. M.; Hicks, C.; Weinmaster, G. and Anderson, D. J. (2000): Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells, Cell 101 [5], pp.499-510.

Mukouyama, Y. S.; Shin, D.; Britsch, S.; Taniguchi, M. and Anderson, D. J. (2002): Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin, Cell 109 [6], pp.693-705.

Muller, U. (1999): Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis, Mech Dev 82 [1-2], pp.3-21.

Olayioye, M. A.; Neve, R. M.; Lane, H. A. and Hynes, N. E. (2000): The ErbB signaling network: receptor heterodimerization in development and cancer, Embo J 19 [13], pp.3159-67..

Ozcelik, C.; Erdmann, B.; Pilz, B.; Wettschureck, N.; Britsch, S.; Hubner, N.; Chien, K. R.; Birchmeier, C. and Garratt, A. N. (2002): Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy, Proc Natl Acad Sci U S A 99 [13], pp.8880-5.

Papadatos, G. A.; Wallerstein, P. M.; Head, C. E.; Ratcliff, R.; Brady, P. A.; Benndorf, K.; Saumarez, R. C.; Trezise, A. E.; Huang, C. L.; Vandenberg, J. I.; Colledge, W. H. and Grace, A. A. (2002): Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a, Proc Natl Acad Sci U S A 99 [9], pp.6210-5.

Paratore, C.; Goerich, D. E.; Suter, U.; Wegner, M. and Sommer, L. (2001): Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling, Development 128 [20], pp.3949-61.

Peifer, M. and Polakis, P. (2000): Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus, Science 287 [5458], pp.1606-9.

Peirano, R. I.; Goerich, D. E.; Riethmacher, D. and Wegner, M. (2000): Protein zero gene expression is regulated by the glial transcription factor Sox10, Mol Cell Biol 20 [9], pp.3198-209.

Peirano, R. I. and Wegner, M. (2000): The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences, Nucleic Acids Res 28 [16], pp.3047-55.

Peles, E.; Ben, Levy R.; Tzahar, E.; Liu, N.; Wen, D. and Yarden, Y. (1993): Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships, Embo J. 12 [3], pp.961-71.

Pevny, L. H. and Lovell-Badge, R. (1997): Sox genes find their feet, Curr Opin Genet Dev 7 [3], pp.338-44.

Pingault, V.; Bondurand, N.; Kuhlbrodt, K.; Goerich, D. E.; Prehu, M. O.; Puliti, A.; Herbarth, B.; Hermans-Borgmeyer, I.; Legius, E.; Matthijs, G.; Amiel, J.; Lyonnet, S.; Ceccherini, I.; Romeo, G.; Smith, J. C.; Read, A. P.; Wegner, M. and Goossens, M. (1998): SOX10 mutations in patients with Waardenburg-Hirschsprung disease, Nat Genet 18 [2], pp.171-3.

Pingault, V.; Bondurand, N.; Le Caignec, C.; Tardieu, S.; Lemort, N.; Dubourg, O.; Le Guern, E.; Goossens, M. and Boespflug-Tanguy, O. (2001): The SOX10 transcription factor: evaluation as a candidate gene for central and peripheral hereditary myelin disorders, J Neurol 248 [6], pp.496-9.

Pingault, V.; Guiochon-Mantel, A.; Bondurand, N.; Faure, C.; Lacroix, C.; Lyonnet, S.; Goossens, M. and Landrieu, P. (2000): Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: a developmental "neural crest syndrome" related to a SOX10 mutation, Ann Neurol 48 [4], pp.671-6.

Plowman, G. D.; Green, J. M.; Culouscou, J. M.; Carlton, G. W.; Rothwell, V. M. and Buckley, S. (1993): Heregulin induces tyrosine phosphorylation of HER4/p180erbB4, Nature 366 [6454], pp.473-5.

Price, S. R.; De Marco Garcia, N. V.; Ranscht, B. and Jessell, T. M. (2002): Regulation of motor neuron pool sorting by differential expression of type II cadherins, Cell 109 [2], pp.205-16.

Pusch, C.; Hustert, E.; Pfeifer, D.; Sudbeck, P.; Kist, R.; Roe, B.; Wang, Z.; Balling, R.; Blin, N. and Scherer, G. (1998): The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor, Hum Genet 103 [2], pp.115-23.

Raff, M. C.; Abney, E.; Brockes, J. P. and Hornby-Smith, A. (1978): Schwann cell growth factors, Cell 15 [3], pp.813-22.

Reissmann, E.; Ernsberger, U.; Francis-West, P. H.; Rueger, D.; Brickell, P. M. and Rohrer, H. (1996): Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons, Development 122 [7], pp.2079-88.

Riethmacher, D.; Sonnenberg, Riethmacher E.; Brinkmann, V.; Yamaai, T.; Lewin, G. R. and Birchmeier, C. (1997): Severe neuropathies in mice with targeted mutations in the ErbB3 receptor, Nature 389 [6652], pp.725-30.

Schlessinger, J. (2000): Cell signaling by receptor tyrosine kinases, Cell 103 [2], pp.211-25..

Schneider, C.; Wicht, H.; Enderich, J.; Wegner, M. and Rohrer, H. (1999): Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons, Neuron 24 [4], pp.861-70.

Schuchardt, A.; D'Agati, V.; Larsson-Blomberg, L.; Costantini, F. and Pachnis, V. (1994): Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret, Nature 367 [6461], pp.380-3.

Shah, N. M.; Groves, A. K. and Anderson, D. J. (1996): Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members, Cell 85 [3], pp.331-43.

Shima, D. T. and Mailhos, C. (2000): Vascular developmental biology: getting nervous, Curr Opin Genet Dev 10 [5], pp.536-42.

Sliwkowski, M. X.; Schaefer, G.; Akita, R. W.; Lofgren, J. A.; Fitzpatrick, V. D.; Nuijens, A.; Fendly, B. M.; Cerione, R. A.; Vandlen, R. L. and Carraway, Kl 3rd (1994): Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin, J. Biol. Chem. 269 [20], pp.14661-5.

Southard-Smith, E. M.; Kos, L. and Pavan, W. J. (1998): Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model, Nat Genet 18 [1], pp.60-4.

Spokony, R. F.; Aoki, Y.; Saint-Germain, N.; Magner-Fink, E. and Saint-Jeannet, J. P. (2002): The transcription factor Sox9 is required for cranial neural crest development in Xenopus, Development 129 [2], pp.421-32.

Suter, U. and Scherer, S. S. (2003): Disease mechanisms in inherited neuropathies, Nat Rev Neurosci 4 [9], pp.714-26.

Szeder, V.; Grim, M.; Halata, Z. and Sieber-Blum, M. (2003): Neural crest origin of mammalian Merkel cells, Dev Biol 253 [2], pp.258-63.

Taniguchi, M.; Yuasa, S.; Fujisawa, H.; Naruse, I.; Saga, S.; Mishina, M. and Yagi, T. (1997): Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection, Neuron 19 [3], pp.519-30.

Thomas, S. A.; Matsumoto, A. M. and Palmiter, R. D. (1995): Noradrenaline is essential for mouse fetal development, Nature 374 [6523], pp.643-6.

Touraine, R. L.; Attie-Bitach, T.; Manceau, E.; Korsch, E.; Sarda, P.; Pingault, V.; Encha-Razavi, F.; Pelet, A.; Auge, J.; Nivelon-Chevallier, A.; Holschneider, A. M.; Munnes, M.; Doerfler, W.; Goossens, M.; Munnich, A.; Vekemans, M. and Lyonnet, S. (2000): Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain, Am J Hum Genet 66 [5], pp.1496-503.

Tzahar, E.; Levkowitz, G.; Karunagaran, D.; Yi, L.; Peles, E.; Lavi, S.; Chang, D.; Liu, N. L.; Yayon, A.; Wen, D. Z. and Yarden, Y. (1994): Erbb-3 and erbb-4 function as the respective low and high affinity receptors of all neu differentiation factor heregulin isoforms, Journal of Biological Chemistry 269 [40], pp.25226-25233.

Wakamatsu, Y.; Maynard, T. M. and Weston, J. A. (2000): Fate determination of neural crest cells by NOTCH-mediated lateral inhibition and asymmetrical cell division during gangliogenesis, Development 127 [13], pp.2811-21.

Wallasch, C.; Weiss, F. U.; Niederfellner, G.; Jallal, B.; Issing, W. and Ullrich, A. (1995): Heregulin-dependent regulation of her2/neu oncogenic signaling by heterodimerization with her3, Embo Journal 14 [17], pp.4267-4275.

Wang, S. and Barres, B. A. (2000): Up a notch: instructing gliogenesis, Neuron 27 [2], pp.197-200.

Wegner, M. (1999): From head to toes: the multiple facets of Sox proteins, Nucleic Acids Res 27 [6], pp.1409-20.

Weinmaster, G.; Roberts, V. J. and Lemke, G. (1991): A homolog of Drosophila Notch expressed during mammalian development, Development 113 [1], pp.199-205.

Wen, D.; Peles, E.; Cupples, R.; Suggs, S. V.; Bacus, S. S.; Luo, Y.; Trail, G.; Hu, S.; Silbiger, S. M.; Levy, R. B. and et, a. l. (1992): Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit, Cell 69 [3], pp.559-72.

Wilson, M. and Koopman, P. (2002): Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators, Curr Opin Genet Dev 12 [4], pp.441-6.

Woldeyesus, M. T.; Britsch, S.; Riethmacher, D.; Xu, L.; Sonnenberg-Riethmacher, E.; Abou-Rebyeh, F.; Harvey, R.; Caroni, P. and Birchmeier, C. (1999): Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development, Genes Dev 13 [19], pp.2538-48..

Wolpowitz, D.; Mason, T. B.; Dietrich, P.; Mendelsohn, M.; Talmage, D. A. and Role, L. W. (2000): Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses, Neuron 25 [1], pp.79-91..

Yamamoto, Y.; Livet, J.; Pollock, R. A.; Garces, A.; Arce, V.; deLapeyriere, O. and Henderson, C. E. (1997): Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons, Development 124 [15], pp.2903-13.

Yang, X.; Kuo, Y.; Devay, P.; Yu, C. and Role, L. (1998): A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis, Neuron 20 [2], pp.255-70.

Yarden, Y. and Sliwkowski, M. X. (2001): Untangling the ErbB signalling network, Nat Rev Mol Cell Biol 2 [2], pp.127-37.

Zhang, D.; Sliwkowski, M. X.; Mark, M.; Frantz, G.; Akita, R.; Sun, Y.; Hillan, K.; Crowley, C.; Brush, J. and Godowski, P. J. (1997): Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4, Proc Natl Acad Sci U S A 94 [18], pp.9562-7.

Zhou, Q. Y.; Quaife, C. J. and Palmiter, R. D. (1995): Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development, Nature 374 [6523], pp.640-3.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: